martes, 25 de diciembre de 2012

National Guideline Clearinghouse | American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis.

full-text ►
National Guideline Clearinghouse | American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis.


National Guideline Clearinghouse (NGC)

December 24, 2012


Guideline Title
American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis.
 
Bibliographic Source(s)
Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA, AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis. American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012 Mar-Apr;18(Suppl 1):1-78. [606 references] PubMed External Web Site Policy
 
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: American Association of Clinical Endocrinologists. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract 2000 Mar-Apr;6(2):162-213.


Endocr Pract. 2012 Mar-Apr;18 Suppl 1:1-78.

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.

PMID:
22522068
[PubMed - indexed for MEDLINE] 
 

Related citations in PubMed

 

No hay comentarios:

Publicar un comentario